Mofezolac
Drug profile
Also known as: N-22
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Mofezolac is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including PTGS1, PTGS1 and PTGS2.
- Molecular targets: PTGS1, PTGS1, PTGS2 and PTGS2 (4 listed in DrugCentral).
- Molecular formula: C19H17NO5; molecular weight 339.35 g/mol.
Mechanism & targets
Molecular targets (4)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | PTGS1 | unknown | IC50 8.85 |
| Prostaglandin G/H synthase 1 | PTGS1 | unknown | IC50 8.85 |
| Prostaglandin G/H synthase 2 | PTGS2 | unknown | IC50 6.36 |
| Prostaglandin G/H synthase 2 | PTGS2 | unknown | IC50 6.36 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | PMDA | — | — |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Mofezolac is on its molecule page.
| Molecular formula | C19H17NO5 |
|---|---|
| Molecular weight | 339.35 g/mol |
| CAS number | 78967-07-4 |
| InChIKey | DJEIHHYCDCTAAH-UHFFFAOYSA-N |
| PubChem CID | 4237 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Mofezolac work?
Its molecular targets in DrugCentral include PTGS1, PTGS1, PTGS2 and PTGS2.
What is the chemical formula of Mofezolac?
Mofezolac has the molecular formula C19H17NO5 and a molecular weight of 339.35 g/mol.
Browse: all drugs starting with M · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1829 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL259972 — compound record and bioactivity
- PubChem CID 4237 — chemical identifiers
- FDA UNII RVJ0BV3H3Y — substance identity
- UniProt P23219 (PTGS1) — target protein
- UniProt P35354 (PTGS2) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.